Leukemia Treatment Program | Lymphoma Treatment Program | Hematologic Malignancies Treatment Program

Erythrocyte Cells and Leukocytes Floating in Blood 3D rendering At Rutgers Cancer Institute of New Jersey, our multidisciplinary team of experts who specialize in leukemia, lymphoma, and other hematologic malignancies combine their expertise in clinical care and translational research to provide you with exceptional personalized care in a compassionate environment. To request an appointment, call 844-CANCERNJ.

Our blood cancer specialists focus on patients with acute and chronic leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, myelodysplasia, myeloproliferative diseases, and other hematologic malignancies in addition to benign blood disorders. They work together to provide the most effective and advanced treatments offered, many available only at NCI-designated Comprehensive Cancer Centers such as ours.

Our care team is comprised of the nation’s most experienced physicians in treating rare and complex blood cancers with clinical trials, immunotherapy, and other cellular therapies, including CAR T-Cell therapy which are FACT (Foundation for the Accreditation of Cellular Therapy) certified. In addition, we offer a wide range of oncology support services to help patients navigate their diagnosis, treatment plan, and recovery.

In collaboration with Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, Rutgers Cancer Institute is home to one of the state’s only blood and marrow transplant (BMT) programs, and is the only one at an NCI-designated Comprehensive Cancer Center. Rutgers Cancer Institute is recognized as a Center of Excellence by the Myelodysplastic Syndromes (MDS) Foundation in the research, diagnosis and treatment of MDS disorders.

To request an appointment, call 844-CANCERNJ. | Find Leukemia/Lymphoma/Hematologic Malignancies Clinical Trials.

Your Hematologic Malignancies Team

Ira Braunschweig, MD

Chief, Section of Transplant and Cell Therapy, Rutgers Cancer Institute
Chief of the Transplant and Cell Therapy Service of the RWJBarnabas Health Oncology Service Line
Director for Cell Therapy and Bone Marrow Transplantation at Robert Wood Johnson University Hospital
Professor of Medicine at Rutgers Robert Wood Johnson Medical School

Andrew M. Evens, DO, MBA, MSc

Associate Director for Clinical Services, Rutgers Cancer Institute;
System Director of Medical Oncology and Oncology Lead for Combined Medical Group, RWJBarnabas Health;
Associate Vice Chancellor for Clinical Innovation and Data Analytics, Rutgers Biomedical and Health Sciences

Neil D. Palmisiano, MD, MS

System Leader for Leukemia, RWJBarnabas Health
Deputy Director of Phase I Therapeutics for Hematologic Malignancies
Co-Medical Director of the Office of Human Research Services, Rutgers Cancer Institute